Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
complement-dependent cytotoxicity (CDC)
complement-mediated cellular cytotoxicity (CDC)
complete remission (CR)
complete remission with partial hematological recovery (CRh)
complete response(s) (CRs) Monoclonal Antibodies Including Immunoconjugates and Cytokine-Directed Agents Multiple Myeloma as a Paradigm for Multi-Targeted Intervention
comprehensive metabolic panel (CMP) Question 4.3 Question 4.4
corticotropin-releasing hormone (CRH)
CP
CPIs
Creutzfeldt-Jakob disease (CJD)
CRh
CRH
CRPC
CSCC
CSF
CTCAE
CTCL
CUL4
cullin 4 (CUL4)
cutaneous squamous cell carcinoma (CSCC)
cutaneous T-cell lymphoma (CTCL)
Cy
cyclin-dependent kinases (CDKs)
cyclophilins (CP)
cyclophosphamide (Cy)
CYP
cytarabine (ara-C) Answer 3.5 Answer 3.7 Antimetabolites: Hydroxyurea, Pyrimidine and Purine Analogs, and L-Asparaginase Purine Analogs Question 3.5 Question 3.7
cytidine deaminase (CDA)
cytochrome P450 (CYP)
Cytokine-directed agents cytokine therapy high-dose interleukin toxicity